Will Tesla Go Up or Down in 2025?
The last few months have been exciting for Tesla and…
Buy
54
G Quote, Financials, Valuation and Earnings
Last price:
$42.90
Seasonality move
:
0.64%
Day range:
$42.68 - $43.28
52-week range:
$30.23 - $47.98
Dividend yield:
1.42%
P/E ratio:
11.79x
P/S ratio:
1.67x
P/B ratio:
3.16x
Volume:
585.7K
Avg. volume:
1.6M
1-year change:
24.23%
Market cap:
$7.6B
Revenue:
$4.5B
EPS (TTM):
$3.64
Analysts' Opinion
-
Consensus RatingGenpact has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 8 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $37.82, Genpact has an estimated upside of 10.46% from its current price of $42.91.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $32.00 representing 100% downside risk from its current price of $42.91.
Fair Value
-
According to the consensus of 10 analysts, Genpact has 10.46% upside to fair value with a price target of $37.82 per share.
G vs. S&P 500
-
Over the past 5 trading days, Genpact has overperformed the S&P 500 by 0.76% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Genpact does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Genpact has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Genpact reported revenues of $1.2B.
Earnings Growth
-
Genpact has grown year-over-year earnings for 8 quarters straight. In the most recent quarter Genpact reported earnings per share of $0.74.
Enterprise value:
8.2B
EV / Invested capital:
2.03x
Price / LTM sales:
1.67x
EV / EBIT:
11.20x
EV / Revenue:
1.75x
PEG ratio (5yr expected):
0.21x
EV / Free cash flow:
15.71x
Price / Operating cash flow:
14.96x
Enterprise value / EBITDA:
9.88x
Gross Profit (TTM):
$1.7B
Return On Assets:
13.45%
Net Income Margin (TTM):
14.22%
Return On Equity:
29.37%
Return On Invested Capital:
18%
Operating Margin:
15%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $4.3B | $4.4B | $4.7B | $1.1B | $1.2B | |
| Gross Profit | $1.5B | $1.5B | $1.7B | $402.8M | $431.4M | |
| Operating Income | $528.7M | $602.5M | $674.5M | $165.7M | $181.7M | |
| EBITDA | $643.8M | $739.2M | $827.3M | $197.8M | $222M | |
| Diluted EPS | $1.78 | $2.32 | $3.64 | $0.64 | $0.74 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.9B | $2.1B | $1.8B | $1.9B | $2.4B | |
| Total Assets | $4.8B | $5B | $4.5B | $4.6B | $5.3B | |
| Current Liabilities | $1.1B | $1.3B | $1.6B | $979M | $1.3B | |
| Total Liabilities | $3B | $3.1B | $2.8B | $2.6B | $2.9B | |
| Total Equity | $1.8B | $2B | $1.7B | $2B | $2.4B | |
| Total Debt | $1.6B | $1.7B | $1.5B | $1.3B | $1.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $460.8M | $528.5M | $604.1M | $161.5M | $228.5M | |
| Cash From Investing | -$122.7M | -$59.4M | -$83.6M | -$14.2M | -$20.3M | |
| Cash From Financing | -$653M | -$438.5M | -$52.1M | -$80.5M | -$109.7M | |
| Free Cash Flow | $400.6M | $472.5M | $520.4M | $147.4M | $208.2M | |
G
Sector
Market Cap
$7.6B
$764.9M
Price % of 52-Week High
89.43%
78.73%
Dividend Yield
1.42%
0%
Shareholder Yield
4.27%
2.31%
1-Year Price Total Return
24.23%
-2.09%
Beta (5-Year)
1.176
0.898
Dividend yield:
1.42%
Annualized payout:
$0.55
Payout ratio:
16.07%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$42.68
200-day SMA
Buy
Level
$36.59
Bollinger Bands (100)
Buy
Level
37.31 - 43.99
Chaikin Money Flow
Buy
Level
48.1M
20-day SMA
Sell
Level
$44.16
Relative Strength Index (RSI14)
Sell
Level
43.57
ADX Line
Buy
Level
12.58
Williams %R
Neutral
Level
-68.8826
50-day SMA
Sell
Level
$42.92
MACD (12, 26)
Sell
Level
-0.32
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Neutral
Level
205.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.3118)
Buy
CA Score
(Annual)
Level (0.2464)
Sell
Beneish M-Score
(Annual)
Level (-2.1628)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.9431)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. It is a General Electric spin-off, which is still a large source of revenue for Genpact.
Stock Forecast FAQ
In the current month, G has received 2 Buy ratings 8 Hold ratings, and 0 Sell ratings. The G average analyst price target in the past 3 months is $37.82.
-
Where Will Genpact Stock Be In 1 Year?
According to analysts, the consensus estimate is that Genpact share price will rise to $37.82 per share over the next 12 months.
-
What Do Analysts Say About Genpact?
Analysts are divided on their view about Genpact share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Genpact is a Sell and believe this share price will drop from its current level to $32.00.
-
What Is Genpact's Price Target?
The price target for Genpact over the next 1-year time period is forecast to be $37.82 according to 10 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is G A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Genpact is a Hold. 8 of 10 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of G?
You can purchase shares of Genpact via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Genpact shares.
-
What Is The Genpact Share Price Today?
Genpact was last trading at $42.90 per share. This represents the most recent stock quote for Genpact. Yesterday, Genpact closed at $42.91 per share.
-
How To Buy Genpact Stock Online?
In order to purchase Genpact stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Coinbase Stock Going Down?
Every way you look at it, Coinbase has had a…
Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 28
Lemonade [LMND] is down 10.69% over the past day.
Sell
50
TSLL alert for Dec 28
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.
Buy
63
SMLR alert for Dec 28
Semler Scientific [SMLR] is down 9.65% over the past day.
